TXMD
TherapeuticsMD, Inc. (NASDAQ)
Healthcare — Drug Manufacturers - Specialty & Generic
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Price History
Fundamentals
| Market Cap | $25.00M |
| P/E Ratio (TTM) | 216.00 |
| Forward P/E | 6.17 |
| EPS (TTM) | $0.01 |
| Dividend Yield | - |
| Profit Margin | 5.34% |
| Revenue Growth | 84.20% |
| ROE | 0.32% |
| Debt/Equity | 21.62 |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 62.3 |
| Beta | 0.60 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $2.95 |
| 52-Week Low | $0.99 |
| 50-Day Avg | $2.06 |
| 200-Day Avg | $1.86 |
| Avg Volume | 38.7K |
| Volume | 21.1K |
Performance Analysis
NEUTRALTXMD presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:35 UTC
Back to Screener Export Report